Bay Shore Trust - Nov 15, 2023 Form 4 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Role: 10%+ Owner
Signature: /s/ Michelle Yanez, Attorney-in-Fact for Brian McNulty, Trustee
Stock symbol: MIRA
Transactions as of: Nov 15, 2023
Transactions value $: $0
Form type: 4
Date filed: 11/17/2023, 05:09 PM
Next filing: Feb 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MIRA	Common Stock Warrant (right to buy)	Award		+700K			700K	Nov 15, 2023	Common Stock	700K	$2.00	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The warrants were issued to MIRALOGX LLC ("MIRALOGX"), a wholly-owned subsidiary of the Bay Shore Trust (the "Trust"), a greater than 10% owner of the Issuer, in connection with an Exclusive License Agreement, dated November 15, 2023, by and between MIRALOGX and the Issuer. The Trust may be deemed to beneficially own the shares held by MIRALOGX but disclaims beneficial ownership except to the extent of its pecuniary interest therein, if any.

Content

The warrants were issued to MIRALOGX LLC ("MIRALOGX"), a wholly-owned subsidiary of the Bay Shore Trust (the "Trust"), a greater than 10% owner of the Issuer, in connection with an Exclusive License Agreement, dated November 15, 2023, by and between MIRALOGX and the Issuer. The Trust may be deemed to beneficially own the shares held by MIRALOGX but disclaims beneficial ownership except to the extent of its pecuniary interest therein, if any.